This webinar is presented by CAMH’s Institute for Mental Health Policy Research.
Join a special talk by Professor Roland R. Griffiths.
Register now.
The H. David Archibald Memorial Lecture Award recognizes an individual who has contributed significantly in the field of addiction research or clinical practice. The award is named after H. David Archibald, founding director of the Addiction Research Foundation, one of the Centre for Addiction and Mental Health's (CAMH) founding organization.
CAMH's Institute for Mental Health Policy Research is pleased to present the 2022 award to Dr. Roland R. Griffiths.
Key speaker
Dr. Roland Griffiths, Ph.D., is the Oliver Lee McCabe, III Professor in the Neuropsychopharmacology of Consciousness in the Departments of Psychiatry and Neurosciences and Director of the Center for Psychedelic and Consciousness Research at the Johns Hopkins University School of Medicine. His principal research focus in both clinical and preclinical laboratories has been on the behavioral and subjective effects of mood-altering drugs and he is author of over 400 scientific publications and has trained more than 50 postdoctoral research fellows. He has conducted extensive research with sedative-hypnotics, caffeine, and novel mood-altering drugs. About 20 year ago, he initiated a research program at Johns Hopkins investigating effects of the classic psychedelic substance psilocybin, the active component in "magic mushrooms." Remarkably, many research participants rate their experience of psilocybin as among the most personally meaningful of their lives, and they attribute enduring positive changes in moods, attitudes and behavior months to years after the experience. Completed and ongoing studies include those in healthy volunteers, in beginning and long-term meditators, and in religious leaders. Therapeutic studies with psilocybin include treatment of psychological distress in cancer patients, major depressive disorder, nicotine addiction, anorexia nervosa, and various other psychiatric disorders. Related studies of brain imaging and drug interactions are examining pharmacological and neural mechanisms of action. His research group has also conducted a series of survey studies characterizing various naturally-occurring and psychedelic-occasioned transformative experiences including mystical experiences, Near Death experiences, and experiences claimed to reduce substance use disorders, depression, and anxiety.
*Please note this webinar will not be recorded.
Comments (1)